As I said, in any business there are new problems every day. At BIOCANCER we had a lot of regulatory problems at first. We had trouble approving projects and even wondered if it was feasible to conduct clinical trials in Brazil, given the regulatory situation. Approvals that in other countries ta...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
